Walvax Biotechnology Co (SZSE:300142) ROCE % : 3.14% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Walvax Biotechnology Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 3.14%.

Walvax Biotechnology Co ROCE % Historical Data

The historical data trend for Walvax Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co ROCE % Chart

Walvax Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.47

19.42

7.60

9.67

4.98

Walvax Biotechnology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															4.76	-5.62	1.96	7.13	3.14

Walvax Biotechnology Co ROCE % Calculation

Walvax Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	602.784	/	( ( (15336.026 - 3508.791)	+	(15588.869 - 3203.907) )	/ 2 )
	=	602.784	/	( (11827.235	+	12384.962)	/ 2 )
	=	602.784	/	12106.0985
	=	4.98 %

Walvax Biotechnology Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	394.444	/	( ( (15086.253 - 2549.274)	+	(15003.709 - 2389.956) )	/ 2 )
	=	394.444	/	( ( 12536.979	+	12613.753 )	/ 2 )
	=	394.444	/	12575.366
	=	3.14 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Walvax Biotechnology Co (SZSE:300142) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Walvax Biotechnology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Kexin Road, No. 395, High-tech Zone, Yunnan Province, Kunming, CHN, 650101

Website

http://www.walvax.com

Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.

Executives

Wu Yun Yan	Executives
Zhao Jin Long	Executives
Yao Wei	Executives
Zhou Hua	Executives
Shi Jing	Executives
Jiang Run Sheng	Directors, executives
Gong Sun Qing	Executives
	Executives
Yuan Lin	Executives
Fang Guo Liang	Executives
Li Yun Chun	Director
Huang Zhen	Director
Zhang Li	Secretary Dong
Yang Hong Wei	Supervisors
Xu Ke Ren	Executives

Walvax Biotechnology Co Headlines

No Headlines